Literature DB >> 25981944

Occurrence of cyclophosphamide and ifosfamide in aqueous environment and their removal by biological and abiotic wastewater treatment processes.

Marjeta Česen1, Tina Kosjek1, Maria Laimou-Geraniou2, Boris Kompare3, Brane Širok4, Dimitra Lambropolou2, Ester Heath5.   

Abstract

Cytostatic drug residues in the aqueous environment are of concern due to their possible adverse effects on non-target organisms. Here we report the occurrence and removal efficiency of cyclophosphamide (CP) and ifosfamide (IF) by biological and abiotic treatments including advanced oxidation processes (AOPs). Cyclophosphamide was detected in hospital wastewaters (14-22,000 ng L(-1)), wastewater treatment plant influents (19-27 ng L(-1)) and effluent (17 ng L(-1)), whereas IF was detected only in hospital wastewaters (48-6800 ng L(-1)). The highest removal efficiency during biological treatment (attached growth biomass in a flow through bioreactor) was 59 ± 15% and 35 ± 9.3% for CP and IF, respectively. Also reported are the removal efficiencies of both compounds from wastewater using hydrodynamic cavitation (HC), ozonation (O3) and/or UV, either individually or in combination with hydrogen peroxide (H2O2). Hydrodynamic cavitation did not remove CP and IF to any significant degree. The highest removal efficiencies: 99 ± 0.71% for CP and 94 ± 2.4% for IF, were achieved using UV/O3/H2O2 at 5 g L(-1) for 120 min. When combined with biological treatment, removal efficiencies were >99% for both compounds. This is the first report of combined biological and AOP treatment of CP and IF from wastewater with a removal efficiency >99%.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biological treatment; Cytostatic; Hydrodynamic cavitation; Occurrence; Ozonation; UV irradiation

Mesh:

Substances:

Year:  2015        PMID: 25981944     DOI: 10.1016/j.scitotenv.2015.04.109

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  5 in total

1.  Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments.

Authors:  Marjeta Česen; Tina Kosjek; Francesco Busetti; Boris Kompare; Ester Heath
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-27       Impact factor: 4.223

2.  First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples.

Authors:  Ester Heath; Marjeta Česen; Noelia Negreira; Miren Lopez de Alda; Laura Ferrando-Climent; Lucie Blahova; Tung Viet Nguyen; Mohamed Adahchour; Achim Ruebel; Neville Llewellyn; Janez Ščančar; Srdjan Novaković; Vesna Mislej; Marjeta Stražar; Damià Barceló; Tina Kosjek
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-15       Impact factor: 4.223

3.  The effects and the toxicity increases caused by bicarbonate, chloride, and other water components during the UV/TiO2 degradation of oxazaphosphorine drugs.

Authors:  Webber Wei-Po Lai; Ying-Chih Chuang; Angela Yu-Chen Lin
Journal:  Environ Sci Pollut Res Int       Date:  2017-04-27       Impact factor: 4.223

4.  Evaluation of uptake of the cytostatic methotrexate in Elliptio complanata mussels by LC-MS/MS.

Authors:  Sylvie Poirier Larabie; Martin Jutras; Grégoire Leclair; Isabelle St-Jean; Christine Kleinert; François Gagné; Christian Gagnon
Journal:  Environ Sci Pollut Res Int       Date:  2022-02-10       Impact factor: 5.190

Review 5.  Occurrence of anticancer drugs in the aquatic environment: a systematic review.

Authors:  Carla Nassour; Stephen J Barton; Shereen Nabhani-Gebara; Yolande Saab; James Barker
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-12       Impact factor: 4.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.